Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Buserelin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buserelin 150micrograms/dose nasal spray
0607020B0AAAAAA
|
Buserelin (Endometriosis) | Buserelin | Endocrine System | 8 |
|
Buserelin 100micrograms/dose nasal spray
0803042B0AAABAB
|
Buserelin (Prostate) | Buserelin | Malignant Disease and Immunosuppression | 4 |
|
Suprefact 100micrograms/dose nasal spray
0803042B0BBABAB
|
Suprefact | Buserelin | Malignant Disease and Immunosuppression | 3 |
|
Suprecur 5.5mg/5.5ml solution for injection vials
0607020B0BBABAB
|
Suprecur | Buserelin | Endocrine System | 2 |
|
Suprefact 5.5mg/5.5ml solution for injection vials
0803042B0BBAAAA
|
Suprefact | Buserelin | Malignant Disease and Immunosuppression | 1 |
|
Buserelin 5.5mg/5.5ml solution for injection vials(Prostate)
0803042B0AAAAAA
|
Buserelin (Prostate) | Buserelin | Malignant Disease and Immunosuppression | No data available |
|
Suprecur 150micrograms/dose nasal spray
0607020B0BBAAAA
|
Suprecur | Buserelin | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.